drugset / Trial / NCT03968744
Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease
NaSingle-groupOpen-labelTreatment
Summary
Patients suffering of Parkinson's Disease will be treated with 50 mg/day of Safinamide per os for 2 weeks (escalation phase). Then, safinamide will be increased up to 100 mg/day and, if tolerated, the treatment will be taken for 10 more weeks (maintenance phase). Total treatment 12 weeks.
Timeline
- Start
- 2019-02-18
- Primary completion
- 2026-02-02
- Completion
- 2026-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Safinamide | Small molecule | 100 mg | Oral |